Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05482490
Other study ID # Perio4
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date October 1, 2022
Est. completion date December 31, 2023

Study information

Verified date July 2022
Source University of Cagliari
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study we intend to carry out aims to analyze the clinical and microbiological effects of a new maintenance protocol for implant-supported hybrid prostheses. The maintenance protocol we propose is based on a sequence of phases that include not only the hygiene and cleaning of the prosthesis and the implants, but also the motivation and reinforcement of oral hygiene through iconographic aid (intraoral photographs of the patient). The proposed hygiene protocol is based on a meticulous preliminary plaque disclosure, followed by a full mouth decontamination of all intraoral mucosae, a decontamination of the secondary components, specific intrasulcular decontamination of the implants depending on whether there are probes greater than or less than 5mm and finally, a decontamination and hygiene of the hybrid prosthesis, all with the help of erythritol powders and the different settings of the AirFlow Prophylaxis Master EMS (Electro Medical Systems S.A., Nyon, Switzerland) device. Clinical parameters such as plaque index (PlI), probing depth (PD), bleeding on probing (BOP) and peri-implant suppuration (PS) will be recorded immediately after removal of the prosthesis and at one month of follow-up. The collection of the microbiological sample will be carried out according to the following procedures: the implant will be isolated by suction and the use of cotton rolls, in order to avoid contamination of saliva. Four sterile endodontic paper points will be inserted into the peri-implant sulcus of each implant, placing them in the mesial, distal, lingual/palatal and buccal sites and removed after 30 seconds with tweezers by placing them in a sterile plastic tube which will be sealed immediately. The same procedure will be performed for each implant. Once the operation is completed, the tubes of each patient (one for each implant and each containing 4 paper points) will be sent for microbiological analysis. The samples will be sent to the Microbiology Laboratory of the Department of Surgical Sciences of the University of Cagliari, in order to analyze the presence of bacteria ofn the peri-implant sulci. DNA from crevicular fluid samples will then be isolated by centrifugation and analyzed by PCR (polymerase chain reaction). This biomolecular technique is based on an enzymatic reaction, in which a heat-resistant DNA polymerase (Taq Polymerase) catalyzes the specific amplification of known DNA sequences. This procedure will be performed before the hygiene protocol, immediately after and at one month of follow-up. Power analysis was employed to determine the sample size by using a .05 significance level and a power of 90% based on an effect size of 0.25. Sample size of a minimum of 130 implants (approximately 25/30 patients carrying implant supported hybrid prostheses) is required to detect significant difference between the parameters measured at the different time points using repeated measures ANOVA, however the recruitment of patients will continue through the entire first period of the execution program with no limitations even after reaching the predetermined number


Description:

The study population will consist of patients presenting at the periodontology departments of the Universities of Cagliari and who need maintenance for implant-supported hybrid prostheses. Patients will be excluded from the study if affected by chronic bronchitis or asthma and major systemic illnesses (i.e. diabetes mellitus, cancer, HIV, bone metabolic diseases or disorders that compromise wound healing, radiation or immunosuppressive therapy). Intake of antibiotics or other medication taken within the previous 28 days that may affect the outcome of the study will prevent inclusion in the study as well as confirmed or suspected intolerance to erythritol or chlorhexidine. The implant-supported fixed complete dental prostheses maintenance protocol will consist in the following steps: 1. One minute rinse with 0.12% chlorhexidine in order to lower the microbial load of the oral cavity 2. Expose peri-apical x-rays with paralleling technique without removing the prosthesis in order to facilitate the alignment (Fig 2) 3. Observe patient oral hygiene maneuvers, use of toothbrush, super floss and inter proximal devices 4. Remove/unscrew the hybrid prosthesis 5. Position the prosthesis on a desk or flat plane with the intaglio surface facing up 6. Take a picture of the intaglio surface of the prosthesis 7. Take a clinical picture of the edentulous arch right after the removal of the prosthesis 8. Apply plaque disclosing agent on the edentulous ridge 9. Show the patient the areas stained by the plaque disclosing agent. 10. Show the patient on a monitor the picture of the intaglio surface of the prosthesis to point out areas where home hygiene can improve. 11. Hand to the patient a printout of the picture of the prosthesis with areas with plaque and calculus highlighted with arrows to better communicate ad reiterate the importance of proper hygiene (Fig 3) 12. Probe dental implants circumferentially using a UNC 15 periodontal probe. Record bleeding on probing (BoP), presence of plaque and probing pocket depth (PPD) at four sites per implant. Asses the tone and consistency of the peri implant soft tissues. 13. Decontaminate oral mucosa, gingiva, cheeks and tongue with the use of supragingival tip and erythritol powder. Set the machine at 50% power, 100% irrigation, keep the tip at 5mm distance form the soft tissues and move it with short back and forth movements at an inclination of 30-60°. 14. Decontaminate secondary implant components. Remove plaque disclosing agent, biofilm and staining with the use of supragingival tip and erythritol powder. Set the machine at 60-100% power, 100% irrigation, keep the tip at 3-5mm distance from the implant component and move it with short back and forth movements at an inclination of 60-90°. 15. Subgingival biofilm removal depends on PPD. Each site is treated specifically. If a site has PPD <5mm, decontaminate with the use of supragingival tip and erythritol powder. Set the machine at 60% power, 100% irrigation, keep the tip at 5mm distance from the peri implant sulcus and move it with short back and forth movements at an inclination of 30-60° and never at 90°. Use the tip 5 seconds per site at most. If a site has PPD >5mm PPD< 10mm, decontaminated with the use of subgingival tip (Perioflow®) and erythritol powder. Set the machine at 20-50% power, 70-100% irrigation (the % depends on peri implant tissue firmness), insert the tip in the peri implant sulcus and move it with short back and forth movements in an apical-coronal direction and is maintain it as parallel as possible to the long axis of the implant. Use the tip 5 consecutive seconds per site at most. 16. Remove, if present, remaining calculus with ultrasonic tip 17. Apply plaque disclosing agent again to double check complete biofilm removal 18. If needed remove remaining biofilm 19. Clean and polish the hybrid prosthesis 20. Reposition/Screw the prosthesis verifying absence of concavities and non-polished areas 21. Review and reinforce oral hygiene instructions 22. Schedule next maintenance visit according to patient's susceptibility Peri-implants sulci will be probed using a UNC 15 periodontal probe at four sites, mesial, distal, lingual/palatal and buccal and clinical parameters such as plaque index (PlI), probing depth (PD), bleeding on probing (BOP) and peri-implant suppuration (PS) will be recorded immediately after removal of the prosthesis and at one month of follow-up. Plaque index (PlI) will be evaluated through the use of a disclosing solution, applied with a cotton bud, at the same 4 sites for each implant. Peri-implant bleeding on probing (BOP) will also be evaluated at the same 4 sites for each implant. For both PlI and BOP, values from 0 to 4 will be recorded, depending on the number of implant surfaces presenting plaque/bleeding, respectively. Peri-implant tissue-suppuration (PS) will dichotomously be assessed (present/absent). The collection of the microbiological sample will be carried out according to the following procedures: the implant will be isolated by suction and the use of cotton rolls, in order to avoid contamination of saliva. Four sterile endodontic paper points will be inserted into the peri-implant sulcus of each implant, placing them in the mesial, distal, lingual/palatal and buccal sites and removed after 30 seconds with tweezers by placing them in a sterile plastic tube which will be sealed immediately. The same procedure will be performed for each implant. Once the operation is completed, the tubes of each patient (one for each implant and each containing 4 paper points) will be sent for microbiological analysis. The samples will be sent to the Microbiology Laboratory of the Department of Surgical Sciences of the University of Cagliari, in order to analyze the presence of bacteria of the peri-implant sulci. DNA from crevicular fluid samples will then be isolated by centrifugation and analyzed by PCR (polymerase chain reaction). This biomolecular technique is based on an enzymatic reaction, in which a heat-resistant DNA polymerase (Taq Polymerase) catalyzes the specific amplification of known DNA sequences. This procedure will be performed before the hygiene protocol, immediately after and at one month of follow-up. Power analysis was employed to determine the sample size by using a .05 significance level and a power of 90% based on an effect size of 0.25. Sample size of 130 implants (approximately 25/30 patients carrying implant supported hybrid prostheses) is required to detect significant difference between the parameters measured at the different time points using repeated measures ANOVA. Descriptive statistics will be calculated, including means, standard deviations, medians, and confidence intervals. Microbiological outcomes measured at baseline, immediately post-maintenance and one month will be analyzed using the one-way repeated measures ANOVA test, while the statistical analysis of the PD, BOP, PlI and PS measurements at baseline and one month will be analyzed using McNemar's test. The level of significance is established at 5% (p = 0.05), and the analysis will be carried out using statistical software (SPSS version 26, IBM).


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 130
Est. completion date December 31, 2023
Est. primary completion date December 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patients with implant-supported hybrid prosthesis Exclusion Criteria: - chronic bronchitis or asthma - major systemic illnesses (i.e. diabetes mellitus, cancer, HIV, bone metabolic diseases or disorders that compromise wound healing, radiation or immunosuppressive therapy) - Intake of antibiotics or other medication taken within the previous 28 days that may affect the outcome of the study - Confirmed or suspected intolerance to erythritol or chlorhexidine.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Maintenance protocol for the hygiene of implant supported prosthesis
Sequence of phases that include the hygiene and cleaning of the prosthesis and the implants, the motivation of the patients and reinforcement of oral hygiene.

Locations

Country Name City State
Italy Policlinico Duilio Casula, AOU Cagliari Monserrato CA

Sponsors (1)

Lead Sponsor Collaborator
University of Cagliari

Country where clinical trial is conducted

Italy, 

References & Publications (4)

Cha JK, Paeng K, Jung UW, Choi SH, Sanz M, Sanz-Martín I. The effect of five mechanical instrumentation protocols on implant surface topography and roughness: A scanning electron microscope and confocal laser scanning microscope analysis. Clin Oral Implan — View Citation

Cobb CM, Daubert DM, Davis K, Deming J, Flemmig TF, Pattison A, Roulet JF, Stambaugh RV. Consensus Conference Findings on Supragingival and Subgingival Air Polishing. Compend Contin Educ Dent. 2017 Feb;38(2):e1-e4. — View Citation

Riben-Grundstrom C, Norderyd O, André U, Renvert S. Treatment of peri-implant mucositis using a glycine powder air-polishing or ultrasonic device: a randomized clinical trial. J Clin Periodontol. 2015 May;42(5):462-9. doi: 10.1111/jcpe.12395. Epub 2015 Ap — View Citation

Taschieri S, Weinstein R, Del Fabbro M, Corbella S. Erythritol-Enriched Air-Polishing Powder for the Surgical Treatment of Peri-Implantitis. ScientificWorldJournal. 2015;2015:802310. doi: 10.1155/2015/802310. Epub 2015 May 6. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical parameters plaque index (PlI) immediately after removal of the prosthesis
Primary Clinical parameters plaque index (PlI) one month of follow-up.
Primary Clinical parameters probing depth (PD) immediately after removal of the prosthesis
Primary Clinical parameters probing depth (PD) at one month of follow-up.
Primary Clinical parameters bleeding on probing (BOP) immediately after removal of the prosthesis
Primary Clinical parameters bleeding on probing (BOP) at one month of follow-up.
Primary Clinical parameters peri-implant suppuration (PS) immediately after removal of the prosthesis
Primary Clinical parameters peri-implant suppuration (PS) at one month of follow-up.
Primary Microbiological parameters Four sterile endodontic paper points will be inserted into the peri-implant sulcus of each implant, placing them in the mesial, distal, lingual/palatal and buccal sites and removed after 30 seconds with tweezers by placing them in a sterile plastic tube which will be sealed immediately. The samples will be sent to the Microbiology Laboratory in order to analyze the presence of bacteria of the peri-implant sulci. immediately after removal of the prosthesis
Primary Microbiological parameters Four sterile endodontic paper points will be inserted into the peri-implant sulcus of each implant, placing them in the mesial, distal, lingual/palatal and buccal sites and removed after 30 seconds with tweezers by placing them in a sterile plastic tube which will be sealed immediately. The samples will be sent to the Microbiology Laboratory in order to analyze the presence of bacteria of the peri-implant sulci. at one month of follow-up.
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05675241 - Characterizing the Inflammation Around Dental Implants
Recruiting NCT04676841 - Wound Contamination During Orthopaedic Surgery
Completed NCT03045458 - Associations of Alveolar Bone Loss and Interleukin-1β Levels in One and Two Stage Surgical Procedures N/A
Not yet recruiting NCT05592327 - Citric Acid Passivation on Implant Abutments for the Prevention of Peri-implant Disease N/A
Completed NCT04120181 - A New Predictor Marker for Cochlear Implants Infection
Completed NCT03343288 - Silver Doped Ceramic Coated Orthopedic Implants N/A
Completed NCT03602209 - Short vs. Long Antibiotic Treatment of Implant-free Osteoarticular Infections N/A
Recruiting NCT05924711 - "Association of Peri-implantitis and Maxillary Sinusitis: a Case-control Study".
Recruiting NCT05146570 - Early Diagnosis of Native and Device-associated Meningitis N/A
Recruiting NCT05024760 - Antiseptic Effects on the Dental Implant Internal Surface Microbiome Early Phase 1
Enrolling by invitation NCT04576052 - Long-term Coated and Non-coated Tibia Nails
Active, not recruiting NCT05983341 - Complications in Pediatric Mechanical Circulatory Assistance: Evaluation of Infection Management.
Recruiting NCT04731025 - Local Antibiotics for Breast Implants Phase 3
Recruiting NCT06075017 - Biofilm Accumulation in Zirconia vs. Titanium Implants N/A
Not yet recruiting NCT03195582 - The Effect of Chlorohexidine Gel on Tissue Healing Following Surgical Exposure of Dental Implants Phase 1/Phase 2
Active, not recruiting NCT06148012 - Investigation Of Marginal Bone Loss In Implants With Different Surface Properties And Geometric Designs: A Retrospective Clinical Study N/A